• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Consumer Cyclical·1375.T
Share

Yukiguni Factory Co., Ltd. Stocks

¥ 1157Last Updated 21.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

¥ 283.27M

¥ 1157
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Yukiguni Maitake Co., Ltd., along with its affiliated entities, produces and distributes mushrooms and various processed food items throughout Japan. Its product portfolio features a range of mushrooms, including Maitake, Eringi, and Buna-Shimeji, alongside prepared rice mixes incorporating Maitake and Eringi. The company also offers Aojiru, a health-focused green juice, and other nutritional food products. Established in 1983, Yukiguni Maitake Co., Ltd. maintains its primary operations in Minamiuonuma, Japan, functioning as a subsidiary under Shinmei Co., Ltd.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.07.2026 21:43

Citrini, Who Spooked the Market with Her AI Threat Forecast, Named Three AI Stocks to Buy

21.07.2026 21:08

Novo has filed a lawsuit against its competitor, Eli Lilly, over advertisements for weight-loss drugs

21.07.2026 20:21

Jefferies Forecasts Meta to Generate Billions in Revenue from AI Glasses. What Will Happen to the Stock?

21.07.2026 19:15

Stock of depression drugmaker Neuronetics adds 25% after BTIG initiation at 'buy'

21.07.2026 18:54

The U.S. president may impose new tariffs on dozens of countries this week — FT

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026